Yogesh Singh

Employment

• Institute of Medical Genetics & Applied Genomics, University of Tübingen Group Leader (µGenomics & scMULTIomics)
  2023 - Present
• Eberhard-Karls-Universität Tübingen Medizinische Fakultät Research Scientist/Group Leader
  2016 - 2023
• Eberhard Karls Universität Tübingen Junior Group Leader
  2014 - 2016
• Royal Veterinary College Department of Comparative Biomedical Sciences Post-Doctoral Scientist
  2011 - 2014
• International Centre For Genetic Engineering and Biotechnology New Delhi Post-Doc Fellow
  2009 - 2011
• Banaras Hindu University Faculty of Science Junior Research Fellow
  2005 - 2006

Education

• Royal Veterinary College Clinical Services Division PhD
  2006 - 2009
• Imperial College London PhD Researcher
  2006 - 2009
• Banaras Hindu University Faculty of Science M.Sc.
  2002 - 2004

Projects & Funding

Projects & funding information is unavailable.

Publications (93)

• Dysregulated NK-cell gene expression defines the enduring symptoms of long COVID-19.
  Frontiers in immunology 2026 DOI: 10.3389/fimmu.2026.1720551
  +Save
• Loss of Parkinson Disease Protein 7 (PARK7) upregulates ROS and cell migration and is associated with recurrent pregnancy loss.
  Molecular medicine (Cambridge, Mass.) 2025 DOI: 10.1186/s10020-025-01344-w
  +Save
• sc-MULTI-omics approach in nano-rare diseases: understanding the pathophysiological mechanism of Mulvihill-Smith Syndrome
  Functional & Integrative Genomics 2025 DOI: 10.1007/s10142-025-01608-y
  +Save
• Optimizing the use of in vitro transcribed SGK1-mRNA as a therapeutic tool to treat female infertility.
  BMC research notes 2025 DOI: 10.1186/s13104-025-07346-5
  +Save
• Single-cell RNA-sequencing highlights a curtailed NK cell function in convalescent COVID-19 pregnant women.
  Frontiers in immunology 2025 DOI: 10.3389/fimmu.2025.1560391
  +Save
• Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer
  Cancer & Metabolism 2025 DOI: 10.1186/s40170-025-00391-5
  +Save
• Longitudinal lipoprotein and inflammatory mediators analysis uncover persisting inflammation and hyperlipidemia following SARS-CoV-2 infection in long COVID-19.
  Metabolomics : Official journal of the Metabolomic Society 2025 DOI: 10.1007/s11306-025-02262-y
  +Save
• Harnessing 2D and 3D human endometrial cell culture models to investigate SARS-CoV-2 infection in early pregnancy
  Clinical Science 2025 DOI: 10.1042/CS20241215
  +Save
• Rel Family Transcription Factor NFAT5 Upregulates COX2 via HIF-1α Activity in Ishikawa and HEC1a Cells
  International Journal of Molecular Sciences 2024 DOI: 10.3390/ijms25073666
  +Save
• Integrative Molecular Structure Elucidation and Construction of an Extended Metabolic Pathway Associated with an Ancient Innate Immune Response in COVID-19 Patients.
  Journal of proteome research 2024 DOI: 10.1021/acs.jproteome.3c00654
  +Save